Teraq Health: Medical Quantum ML Platform Now Live
We are excited to announce that Teraq Health, our quantum-enhanced medical machine learning platform, is now live and available for healthcare organizations. This marks a significant milestone in bringing quantum computing advantages to clinical workflows, from rare disease detection to secure patient data processing.
Platform Live Now
Access Teraq Health at www.teraq.ai/teraq-health to explore quantum-enhanced clinical form processing, medical imaging analysis, and secure data pipelines.
Why Quantum ML for Healthcare?
Healthcare data presents unique challenges that quantum-enhanced machine learning is particularly well-suited to address:
- Rare Event Detection: Finding rare diseases, adverse drug reactions, and unusual biomarker patterns in massive datasets where classical methods struggle
- High-Dimensional Data: Processing complex electronic health records (EHR) with thousands of features per patient
- Data Security: HIPAA-compliant processing with quantum key distribution (QKD) for unconditionally secure transmission
- Time-Critical Decisions: Faster inference for conditions like sepsis where every minute counts
(LLM Distillation)
(Survival Prediction)
(Sepsis Biomarkers)
(Q-ViT Models)
Key Capabilities
1. Quantum-Enhanced LLM Distillation
Large Language Models are transforming clinical documentation, but their memory requirements often exceed what's available in hospital IT infrastructure. Our quantum-enhanced distillation process uses Quantum Singular Value Decomposition (QSVD) to compress LLMs while preserving critical medical knowledge.
| Model | Original Size | Distilled Size | Memory Reduction |
|---|---|---|---|
| Clinical BERT | 440 MB | 110 MB | 4x |
| BioGPT-Large | 1.5 GB | 380 MB | 4x |
| Med-LLaMA-7B | 14 GB | 2.8 GB | 5x |
2. Quantum-Enhanced Survival Prediction
Survival prediction is critical for treatment decisions, clinical trial enrollment, and resource planning. Our quantum-enhanced survival models use Quantum Kernel Methods to capture complex, non-linear interactions between patient features that classical Cox regression models miss.
| Application | Classical C-Index | Quantum C-Index | Improvement |
|---|---|---|---|
| Bone Marrow Transplant | 0.72 | 0.81 | +12.5% |
| Lung Cancer Prognosis | 0.68 | 0.76 | +11.8% |
| ICU Mortality Risk | 0.75 | 0.83 | +10.7% |
3. Quantum-Enhanced Clinical Form Processing
Our AI-powered form processing system uses quantum machine learning to extract and validate data from clinical documents with unprecedented accuracy. The system handles CIBMTR forms, clinical trial documentation, and standard medical records.
95% Field Accuracy
Quantum-enhanced extraction vs 85% classical
30 Seconds per Form
Down from 2-5 minutes classical processing
HIPAA Compliant
QKD-secured data transmission available
Anomaly Detection
95% recall on data inconsistencies
4. Quantum Raman Spectroscopy for Sepsis Detection
Sepsis affects 1.7 million adults annually in the US, with 270,000 deaths. Current detection methods take 24-72 hours. Our quantum-enhanced Raman spectroscopy platform enables detection in under 30 minutes.
| Biomarker | Classical Limit | Quantum-Enhanced | Improvement |
|---|---|---|---|
| Procalcitonin (PCT) | 1 ng/mL | 0.1 ng/mL | 10x |
| C-Reactive Protein | 50 mg/L | 5 mg/L | 10x |
| Lactate | 1 mmol/L | 0.2 mmol/L | 5x |
| IL-6 | 200 pg/mL | 20 pg/mL | 10x |
| Time to Result | 24-72 hours | <30 minutes | 48-144x |
The quantum advantage comes from squeezed light sources that reduce measurement noise below the shot-noise limit, enabling detection of biomarkers at concentrations previously undetectable with classical methods.
5. Rare Disease Detection with QuBoost
Our QuBoost algorithm combines quantum feature selection with gradient boosting for exceptional performance on imbalanced medical datasets. This is critical for detecting rare conditions that appear in less than 1% of patient populations.
| Disease Prevalence | QuBoost (Quantum) | XGBoost (Classical) | Advantage |
|---|---|---|---|
| 1% (very rare) | 100% recall | 90% recall | +10% |
| 3% (rare) | 98.5% recall | 88.5% recall | +10% |
| 5% (uncommon) | 96.2% recall | 86.0% recall | +10.2% |
6. Quantum Vision Transformer (Q-ViT) for Medical Imaging
Our Q-ViT architecture applies quantum computing principles to medical image analysis, achieving state-of-the-art results on chest X-ray classification and CT scan segmentation with 4x fewer parameters than classical vision transformers.
Currently available for:
- Chest X-ray classification (CXR8 dataset validated)
- CT scan segmentation
- Multi-modal medical image fusion
How It Works: The Quantum Advantage
Teraq Health leverages several quantum computing techniques to achieve these results:
- Quantum Feature Selection (QAOA): Finds optimal feature subsets from high-dimensional EHR data exponentially faster than classical methods
- Squeezed Light Sensing: 6 dB squeezing provides 4x SNR improvement for Raman spectroscopy, enabling detection of lower biomarker concentrations
- Matrix Product State (MPS) Encoding: Efficiently represents complex medical data patterns in quantum circuits with logarithmic qubit scaling
- Quantum Key Distribution: Unconditionally secure encryption for HIPAA-compliant patient data transmission
Getting Started
Teraq Health is available now for healthcare organizations, research institutions, and clinical trial sponsors. Our platform integrates with existing EHR systems and can be deployed on-premises or accessed via our secure cloud.
Clinical Form Processing
Start with batch upload or API integration
Sepsis Detection
Pilot programs available for hospitals
Rare Disease Screening
Custom QuBoost models for your data
Medical Imaging
Q-ViT inference API available
Ready to Transform Your Clinical Workflows?
Contact us to schedule a demo or start a pilot program for your organization.
Request DemoWhat's Next
We are continuously expanding Teraq Health's capabilities. Upcoming features include:
- Q2 2026: Quantum LLM integration for clinical note summarization
- Q3 2026: Multi-hospital network deployment with QKD
- Q4 2026: Expanded biomarker panel for sepsis (10+ markers)
- 2027: Real-time distributed sensing networks
Stay tuned for more updates, and don't hesitate to reach out if you have questions about how Teraq Health can benefit your organization.